CliffBio
small molecule

LEVOCETIRIZINE DIHYDROCHLORIDE

LEVOCETIRIZINE DIHYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyTaro Pharmaceutical Industries →See this company's full patent-cliff portfolio

Drug detail

Brand nameLEVOCETIRIZINE DIHYDROCHLORIDE
Active ingredientLEVOCETIRIZINE DIHYDROCHLORIDE
Strength2.5MG/5ML
Dosage formSOLUTION
RouteORAL
ModalitySmall molecule
FDA approvalJuly 2013
Marketing statusDISCN

More from Taro Pharmaceutical Industries

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.